Johnson & Johnson Innovation

Johnson & Johnson Innovation is owned by Johnson & Johnson.

Johnson & Johnson is one of the...

• Forbes Global 2000 (#34);
• Fortune 500 (#36);
• Global Fortune 500 (#94);
• Russell 3000;
• S&P 500.

Johnson & Johnson is a company listed under the stock ticker JNJ (US).

Johnson & Johnson has a direct presence in 25 countries.

Johnson & Johnson has 68 subsidiaries including Auris Health, Biosense Webster and DePuy Synthes.

They are in:

• Pharmaceuticals65%
• Medical Equipment14%
• Other20%

Acquisition, funding and merger involving Johnson & Johnson.

• Johnson & Johnson has acquired Momenta Pharmaceuticals (posted on October 1 2020).

View the org chart displaying its 44 main executives

Most searched biographies at Johnson & Johnson Innovation

• Chris Picariello, President
• Melinda Richter, Global Head of JLabs
• Jackie Benson, Vice President, Immunology Scientific Innovation

Popular executive movements at Johnson & Johnson

• Michael Sneed, Executive Vice President, Global Corporate Affairs and Chief Communication Officer, will retire on Apr. 1, 2022  (posted on December 10 2021)..
• Vanessa Broadhurst who is Group Chairman, Global Commercial Strategy Organization , will be promoted to Executive Vice President, Global Corporate Affairs on Jan. 3, 2022  (posted on December 10 2021)..
• Jessica Moore will join the company as Vice President of Investor Relations on Nov. 1, 2021  (posted on October 14 2021)..

Click here to view some more movements at Johnson & Johnson

Create an alert
to follow the executive moves at Johnson & Johnson Innovation.

Johnson & Johnson has 1,890 competitors including Neptune Wellness Solutions (Canada), Eurofins (Luxembourg) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Gelesis has filed its IPO. Its stock ticker will be GLS. (posted on January 14 2022).
• DNA Script has just announced a $200 Million fundraising. (posted on January 13 2022).
• Transcarent becomes a unicorn with its fundraising of $200 Million. (posted on January 13 2022).

Popular contacts in Biotechnology

• Daniel Schmachtenberger - Director of Research and Development at Neurohacker Collective
• Heiko Von Der Leyen - Medical Director at Orgenesis
• Franz-Werner Haas - Chief Executive Officer at CureVac

Learn more about the Biotechnology industry >

Press releases by Johnson & Johnson Innovation

• ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
• Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies | Fate Therapeutics, Inc.
• OrthoSpin Ltd. Raises up to US$5 Million in Series B Financing
• Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen
• Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
• Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.
• Cyprio Wins Women Startup Challenge Europe HealthTech
• Adicet Bio Raises $80M in Series B Financing
• https://www.jnjinnovation.com/sites/default/files/pressreleases/jji_jpm18_press_release_0.pdf
• Johnson & Johnson Announces Completion of Acquisition of Actelion | Johnson & Johnson
• View more press releases Close

Social media about Johnson & Johnson Innovation

• Johnson & Johnson Innovation on Wikipedia, Google News & Yahoo Finance
• Johnson & Johnson Innovation on LinkedIn, Twitter & YouTube

Contact by email its executives including Chris Picariello

Call Johnson & Johnson Innovation at +1 732...

View the org chart

Register to receive your alert

Report an error